Price$1.28-2.05 (-61.53%)
2026-03-042026-06-05
News · 26 weeks59-31%
2025-12-142026-06-07
Mix4690d
- Insider24(52%)
- SEC Filings14(30%)
- Offering4(9%)
- Other2(4%)
- Leadership1(2%)
- Earnings1(2%)
Latest news
25 items- SECCibus Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - Cibus, Inc. (0001705843) (Filer)
- INSIDERSEC Form 4 filed by Director Finn Mark Terrence4 - Cibus, Inc. (0001705843) (Issuer)
- INSIDERSEC Form 4 filed by Director Moretti August J4 - Cibus, Inc. (0001705843) (Issuer)
- INSIDERSEC Form 4 filed by Director Riggs Rory B4 - Cibus, Inc. (0001705843) (Issuer)
- INSIDERDirector Prante Gerhard was granted 64,748 shares, increasing direct ownership by 161% to 104,945 units (SEC Form 4)4 - Cibus, Inc. (0001705843) (Issuer)
- INSIDERDirector Lehmann Jean-Pierre Jules was granted 64,748 shares, increasing direct ownership by 9% to 763,904 units (SEC Form 4)4 - Cibus, Inc. (0001705843) (Issuer)
- INSIDERSEC Form 4 filed by Director Box Kimberly Ann4 - Cibus, Inc. (0001705843) (Issuer)
- INSIDERSEC Form 4 filed by Director Wichner Craig4 - Cibus, Inc. (0001705843) (Issuer)
- INSIDERDirector Urban Thomas was granted 64,748 shares (SEC Form 4)4 - Cibus, Inc. (0001705843) (Issuer)
- SECSEC Form EFFECT filed by Cibus Inc.EFFECT - Cibus, Inc. (0001705843) (Filer)
- SECSEC Form 424B3 filed by Cibus Inc.424B3 - Cibus, Inc. (0001705843) (Filer)
- SECSEC Form S-3 filed by Cibus Inc.S-3 - Cibus, Inc. (0001705843) (Filer)
- SECSEC Form 10-Q filed by Cibus Inc.10-Q - Cibus, Inc. (0001705843) (Filer)
- SECCibus Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Cibus, Inc. (0001705843) (Filer)
- PRCibus Reports First Quarter Financial Results and Provides Business UpdateSAN DIEGO, May 14, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) (the "Company"), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced its financial results for the quarter ended March 31, 2026, and provided a business update. Management will host a conference call and webcast today at 4:30 p.m. ET. Management Commentary Peter Beetham, Interim Chief Executive Officer of Cibus, commented, "We are pleased to report continued momentum across our priority programs during the first quarter of 2026. We continue to work with our global seed company partners to change the scale and speed of breeding. Our Rice herbicide toleranc
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Cibus Inc.SCHEDULE 13G/A - Cibus, Inc. (0001705843) (Subject)
- PRCibus Announces Transfer of Gene-Edited Herbicide Tolerance Traits in Interoc Rice Seeds for Testing and ProductionSAN DIEGO, May 04, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company specializing in the development and licensing of high-value plant traits, today announced the transfer of gene-edited materials for herbicide tolerance in rice to its partner, Interoc. This transition facilitates the commencement by Interoc of testing and production in anticipation of the forthcoming launch of Interoc's CIBUS® enhanced seed products into the Latin American agricultural sector. "Our collaboration with Cibus continues to deliver significant value," said Fernando De La Puente, Corporate Vice President at Interoc. "Rice is a critical crop for the Latin American eco
- PRCibus to Report First Quarter 2026 Financial Results on May 14, 2026 After the Market Close and Host Conference CallSAN DIEGO, April 30, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that the company will report first quarter 2026 financial results on Thursday, May 14, 2026. Cibus' management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates. Title: Cibus, Inc. First Quarter 2026 Results Conference Call Event Date: Thursday, May 14, 2026 Time: 4:30 p.m. ET Participant Numbers: +1-800-274-8461 (U.S.), +1-203-518-9814 (International)The conference ID "CIBUS" or 24287 will be requir
- INSIDERAmendment: CFO Broos Carlo was granted 57,000 shares, increasing direct ownership by 59% to 154,275 units (SEC Form 4)4/A - Cibus, Inc. (0001705843) (Issuer)
- INSIDERSEC Form 4 filed by Director Urban Thomas4 - Cibus, Inc. (0001705843) (Issuer)
- INSIDERSr VP, Research Sauer Noel was granted 38,000 shares, increasing direct ownership by 37% to 139,879 units (SEC Form 4)4 - Cibus, Inc. (0001705843) (Issuer)
- INSIDERCAO, Gen Csl & Corp Secy Stokes Jason was granted 57,000 shares, increasing direct ownership by 51% to 167,865 units (SEC Form 4)4 - Cibus, Inc. (0001705843) (Issuer)
- INSIDERCFO Broos Carlo was granted 57,000 shares, increasing direct ownership by 59% to 154,275 units (SEC Form 4)4 - Cibus, Inc. (0001705843) (Issuer)
- INSIDERChief Scientific Officer & EVP Gocal Gregory Francis William was granted 57,000 shares, increasing direct ownership by 16% to 422,890 units (SEC Form 4)4 - Cibus, Inc. (0001705843) (Issuer)
- INSIDERInterim CEO, Pres & COO Beetham Peter was granted 195,000 shares, increasing direct ownership by 40% to 686,825 units (SEC Form 4)4 - Cibus, Inc. (0001705843) (Issuer)
CBUS FAQ
6 questionsWhere does CBUS stock trade?
Cibus Inc. (CBUS) is listed on NASDAQ.What sector and industry is CBUS in?
Cibus Inc. operates in the Industrials sector, Agricultural Chemicals industry.When did Cibus Inc. go public?
Cibus Inc. (CBUS) completed its IPO in 2017.What are analysts saying about CBUS?
Cibus Inc. has had 4 recent analyst actions on file. The most recent action was from Alliance Global Partners: Buy with a $2500.00 price target on 2024-07-29. Recent price targets range from $2200.00 to $3000.00.What companies are similar to CBUS?
Notable peers in the same industry include NTR (Nutrien Ltd.), CF (CF Industries Holdings Inc.), ICL (ICL Group Ltd.), MOS (Mosaic Company), SMG (Scotts Miracle-Gro Company). Compare CBUS side-by-side with any of them on Quantisnow.How can I track CBUS on Quantisnow?
Quantisnow aggregates Cibus Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CBUS to receive live email and push alerts on every new disclosure.